Clinical Scorecard: Acupuncture's Role in Managing Complications After Chemoradiotherapy in Lung Cancer Patients with Bone Metastases: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Key Mechanisms
Involvement of formin-like protein 1 (FMNL1) and semaphorin 4D (Sema4D) in bone metastasis and neuropathy, as reported in the literature.
Target Population
Care Setting
Key Highlights
CIPN severity improved from Grade III to Grade I post-treatment, as reported.
VAS score decreased from 7.8 to 3 post-treatment, as reported.
HHS increased from 35 to 80 post-treatment, as reported.
No adverse events reported during the treatment period, as stated.
Guideline-Based Recommendations
Diagnosis
Management
Acupuncture is mentioned in the NCCN guidelines as an adjunct treatment for CIPN and related symptoms.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
A 52-year-old male with a history of lung cancer and bone metastases
Acupuncture led to cessation of analgesic medications and high patient satisfaction
Clinical Best Practices
Incorporate acupuncture into the management plan for patients with CIPN, as suggested in the literature.
Monitor patient outcomes using validated scoring systems, as recommended.
Ensure acupuncture is performed by qualified practitioners, as stated.
